363 related articles for article (PubMed ID: 17906643)
1. Design of selective nuclear receptor modulators: RAR and RXR as a case study.
de Lera AR; Bourguet W; Altucci L; Gronemeyer H
Nat Rev Drug Discov; 2007 Oct; 6(10):811-20. PubMed ID: 17906643
[TBL] [Abstract][Full Text] [Related]
2. RAR and RXR modulation in cancer and metabolic disease.
Altucci L; Leibowitz MD; Ogilvie KM; de Lera AR; Gronemeyer H
Nat Rev Drug Discov; 2007 Oct; 6(10):793-810. PubMed ID: 17906642
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis for designing selective modulators of retinoic acid receptor transcriptional activities.
Lefebvre P
Curr Drug Targets Immune Endocr Metabol Disord; 2001 Aug; 1(2):153-64. PubMed ID: 12476796
[TBL] [Abstract][Full Text] [Related]
4. Retinoid receptors and therapeutic applications of RAR/RXR modulators.
le Maire A; Alvarez S; Shankaranarayanan P; Lera AR; Bourguet W; Gronemeyer H
Curr Top Med Chem; 2012; 12(6):505-27. PubMed ID: 22242853
[TBL] [Abstract][Full Text] [Related]
5. Receptor specificity of retinoid-induced epidermal hyperplasia: effect of RXR-selective agonists and correlation with topical irritation.
Thacher SM; Standeven AM; Athanikar J; Kopper S; Castilleja O; Escobar M; Beard RL; Chandraratna RA
J Pharmacol Exp Ther; 1997 Aug; 282(2):528-34. PubMed ID: 9262312
[TBL] [Abstract][Full Text] [Related]
6. Diphenylamine-based retinoid antagonists: regulation of RAR and RXR function depending on the N-substituent.
Ohta K; Kawachi E; Fukasawa H; Shudo K; Kagechika H
Bioorg Med Chem; 2011 Apr; 19(8):2501-7. PubMed ID: 21459577
[TBL] [Abstract][Full Text] [Related]
7. Retinoic acid receptor beta,gamma-selective ligands: synthesis and biological activity of 6-substituted 2-naphthoic acid retinoids.
Yu KL; Spinazze P; Ostrowski J; Currier SJ; Pack EJ; Hammer L; Roalsvig T; Honeyman JA; Tortolani DR; Reczek PR; Mansuri MM; Starrett JE
J Med Chem; 1996 Jun; 39(12):2411-21. PubMed ID: 8691435
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for engineering of retinoic acid receptor isotype-selective agonists and antagonists.
Géhin M; Vivat V; Wurtz JM; Losson R; Chambon P; Moras D; Gronemeyer H
Chem Biol; 1999 Aug; 6(8):519-29. PubMed ID: 10421757
[TBL] [Abstract][Full Text] [Related]
9. Determinants of retinoid X receptor transcriptional antagonism.
Cavasotto CN; Liu G; James SY; Hobbs PD; Peterson VJ; Bhattacharya AA; Kolluri SK; Zhang XK; Leid M; Abagyan R; Liddington RC; Dawson MI
J Med Chem; 2004 Aug; 47(18):4360-72. PubMed ID: 15317450
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and evaluation of retinoids with novel bulky hydrophobic partial structures.
Amano Y; Noguchi M; Nakagomi M; Muratake H; Fukasawa H; Shudo K
Bioorg Med Chem; 2013 Jul; 21(14):4342-50. PubMed ID: 23685180
[TBL] [Abstract][Full Text] [Related]
11. Synthetic retinoids: structure-activity relationships.
Barnard JH; Collings JC; Whiting A; Przyborski SA; Marder TB
Chemistry; 2009 Nov; 15(43):11430-42. PubMed ID: 19821467
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic applications for ligands of retinoid receptors.
Thacher SM; Vasudevan J; Chandraratna RA
Curr Pharm Des; 2000 Jan; 6(1):25-58. PubMed ID: 10637371
[TBL] [Abstract][Full Text] [Related]
13. Pyrazine arotinoids with inverse agonist activities on the retinoid and rexinoid receptors.
García J; Khanwalkar H; Pereira R; Erb C; Voegel JJ; Collette P; Mauvais P; Bourguet W; Gronemeyer H; de Lera AR
Chembiochem; 2009 May; 10(7):1252-9. PubMed ID: 19343742
[TBL] [Abstract][Full Text] [Related]
14. Ligand recognition by RAR and RXR receptors: binding and selectivity.
Sussman F; de Lera AR
J Med Chem; 2005 Oct; 48(20):6212-9. PubMed ID: 16190748
[TBL] [Abstract][Full Text] [Related]
15. Retinoid receptor subtype-selective modulators through synthetic modifications of RARgamma agonists.
Alvarez S; Alvarez R; Khanwalkar H; Germain P; Lemaire G; Rodríguez-Barrios F; Gronemeyer H; de Lera AR
Bioorg Med Chem; 2009 Jul; 17(13):4345-59. PubMed ID: 19482478
[TBL] [Abstract][Full Text] [Related]
16. Selective retinoic acid receptor ligands for rheumatoid arthritis.
Beehler BC; Brinckerhoff CE; Ostrowski J
Curr Opin Investig Drugs; 2004 Nov; 5(11):1153-7. PubMed ID: 15573865
[TBL] [Abstract][Full Text] [Related]
17. Effects of retinoid ligands on RIP140: molecular interaction with retinoid receptors and biological activity.
Farooqui M; Franco PJ; Thompson J; Kagechika H; Chandraratna RA; Banaszak L; Wei LN
Biochemistry; 2003 Feb; 42(4):971-9. PubMed ID: 12549917
[TBL] [Abstract][Full Text] [Related]
18. Selective RXR modulators for the treatment of type II diabetes.
Faul MM; Grese TA
Curr Opin Drug Discov Devel; 2002 Nov; 5(6):974-85. PubMed ID: 12478728
[TBL] [Abstract][Full Text] [Related]
19. The retinoid X receptor and its ligands: versatile regulators of metabolic function, cell differentiation and cell death.
Ahuja HS; Szanto A; Nagy L; Davies PJ
J Biol Regul Homeost Agents; 2003; 17(1):29-45. PubMed ID: 12757020
[TBL] [Abstract][Full Text] [Related]
20. Marked improvement induced in photoaged skin of hairless mouse by ER36009, a novel RARgamma-specific retinoid, but not by ER35794, an RXR-selective agonist.
Sakuta T; Kanayama T
Int J Dermatol; 2006 Nov; 45(11):1288-95. PubMed ID: 17076708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
